MedTrace Logo

Effect and Tolerance of Standardized Exclusive Dry Extracts of Curcuma Longa and of Boswellia Serrata Among People With Hand Joint Discomfort and Dysfunction

NCT05570123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2025-04-08

No results posted yet for this study

Summary

The objective of the study is to evaluate the effect and tolerance of standardized exclusive dry extracts of Curcuma longa (CURTIL03) and of Boswellia serrata (BOSTIL01) among people with hand joint discomfort and dysfunction.

The study is prospective, randomized, double-blinded, placebo-controlled with 2 parallel-groups in 200 participants. The study is multicentric and will be done by 11 investigators located in Belgium including rheumatologists, sports and rehabilitation physicians, physical therapists, or any hand articular disease specialists.

Conditions

  • Hand Joint Discomfort
  • Hand Joint Dysfunction

Interventions

DIETARY_SUPPLEMENT

Flexofytol Forte

standardized exclusive dry extracts of Curcuma longa and Boswellia serrata. 2 tablets a day, one in the morning, one in the evening

DIETARY_SUPPLEMENT

Placebo

2 tablets a day, one in the morning, one in the evening

Sponsors & Collaborators

  • Artialis

    collaborator INDUSTRY

  • Tilman S.A.

    lead INDUSTRY

Principal Investigators

  • Ruth Wittoek (National coordinator), Pr, MD · UZ Gent

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-14
Primary Completion
2024-01-23
Completion
2024-01-23

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05570123 on ClinicalTrials.gov